Arcturus Therapeutics
Arcturus Therapeutics's Overview
Arcturus Therapeutics Holdings Inc. is a global late-stage clinical messenger RNA medicines company focused on the discovery, development, and commercialization of therapeutics for rare diseases and vaccines. Arcturus’s proprietary technologies include its STARR™ mRNA technology (self-amplifying mRNA) and LUNAR® lipid-mediated nanoparticle delivery system. The company's pipeline includes vaccine candidates for COVID-19 and influenza, as well as therapeutic candidates for ornithine transcarbamylase (OTC) deficiency and cystic fibrosis. Arcturus is dedicated to advancing RNA medicines to address significant unmet medical needs.
Where is Arcturus Therapeutics's Headquarters?
HQ Function
Primary center for research and development, corporate operations, clinical development oversight, and strategic decision-making.
Notable Features:
State-of-the-art laboratory facilities for mRNA research, process development, and analytical sciences; collaborative office spaces designed to foster innovation.
Work Culture:
A dynamic, science-driven environment focused on innovation, collaboration, and a commitment to developing transformative medicines. Emphasizes agility and a patient-centric approach in a fast-paced biotech setting.
HQ Significance:
Serves as the global R&D and corporate nerve center, driving the company's strategy, pipeline development, and business operations in the pioneering field of mRNA therapeutics.
Values Reflected in HQ: Innovation, scientific excellence, collaboration, and a commitment to addressing unmet medical needs through cutting-edge RNA technology.
Location:
Arcturus Therapeutics operates globally with its headquarters in San Diego, USA, and significant operations including R&D and manufacturing in Singapore. The company manages worldwide clinical trials and collaborates with international partners to advance its mRNA medicines and vaccines. Its global functions encompass research, clinical development, manufacturing, regulatory affairs, and business development to serve patients internationally.
Street Address:
10628 Science Center Drive, Suite 250
City:
San Diego
State/Province:
California
Country:
USA
Arcturus Therapeutics's Global Presence
Singapore, Singapore
Address: Leased laboratory, office, and manufacturing facility space within Singapore's advanced biotech and pharmaceutical manufacturing ecosystem. Specific public address not listed.
Strategic hub for manufacturing, R&D collaboration, supporting clinical development in Asia, and strengthening global supply chain capabilities.
Buying Intent Signals for Arcturus Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Arcturus Therapeutics
As of April 2025, Arcturus Therapeutics' leadership includes:
Investors of Arcturus Therapeutics
Arcturus Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Arcturus Therapeutics has seen key leadership appointments in the past year, strengthening its C-suite in development, medical, and finance roles. These include a new Chief Development Officer, Chief Medical Officer, and Chief Financial Officer.
Departures
New Appointments:
Technology (Tech Stack) used by Arcturus Therapeutics
Discover the tools Arcturus Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Arcturus Therapeutics Email Formats and Examples
Arcturus Therapeutics likely utilizes a common corporate email format, primarily using the first initial followed by the last name. Variations might exist but this is the most probable structure.
[first_initial][last]@arcturusrx.com
Format
jpayne@arcturusrx.com
Example
85%
Success rate
News and media
Arcturus Therapeutics • February 28, 2024
Arcturus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Arcturus announced its financial results for Q4 and full year 2023, highlighting progress in its vaccine and therapeutic programs, including advancements with its COVID-19 and flu vaccine candidates and upcoming data for its rare disease programs....more
Arcturus Therapeutics • March 18, 2024
Arcturus Therapeutics Appoints Jing Lनोई Maroto, M.D. as Chief Development Officer
Arcturus announced the appointment of Dr. Jing Lनोई Maroto as its new Chief Development Officer. Dr. Maroto brings extensive experience in global clinical development and regulatory affairs to steer Arcturus's pipeline....more
Arcturus Therapeutics • December 11, 2023
Arcturus Therapeutics Announces Positive Topline Results from Japan Phase 3 Study of ARCT-154 (KostaCov) COVID-19 Vaccine
The company reported positive topline results from a Phase 3 study of its ARCT-154 (KostaCov) COVID-19 vaccine booster in Japan, demonstrating non-inferiority against a primary endpoint of neutralizing antibody response compared to Comirnaty....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Arcturus Therapeutics, are just a search away.